Evidence map›Paper›PMID 42040403›Full record

ReviewACS omega2026

Engineered Nanomaterial-Based Photocatalysts for Efficient and Sustainable Degradation of Antibiotics in Water: A Review.

Jyoti Rawat, Charu Dwivedi, Bertin Anzaldo, Pankaj Sharma

Abstract readReview
In one paragraph

Review in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jyoti RawatInstituto de Química, UNAM, Circuito Exterior, Coyoacán CDMX 04510, México.ORCID https://orcid.org/0000-0002-0694-0074
Charu DwivediDepartment of Chemistry, School of Physical Sciences, Doon University, Dehradun, Uttarakhand 248001, India.
Bertin AnzaldoBenemérita Universidad Autónoma de Puebla, Laboratorio de Síntesis de Complejos, Facultad de Ciencias Químicas, Puebla, Pue. C.P.72592, México.ORCID https://orcid.org/0000-0003-0667-2812
Pankaj SharmaInstituto de Química, UNAM, Circuito Exterior, Coyoacán CDMX 04510, México.ORCID https://orcid.org/0000-0002-8725-8041

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The widespread use of antibiotics in healthcare, agriculture, and animal husbandry has led to their persistent presence in aquatic environments, posing significant ecological and public health risks. Photocatalytic degradation has emerged as a promising advanced oxidation process for the efficient breakdown of antibiotics in water. Owing to their high surface area, directional charge transport, and enhanced reactive oxygen species generation, one-dimensional (1D) nanomaterials exhibit superior photocatalytic performance. Unlike previous reviews, this study integrates synthesis strategies, material characterization, degradation mechanisms, and evaluations of stability and reusability, while systematically addressing reproducibility, scalability, and long-term operational stability, key challenges that determine the reliability and practical deployment of photocatalytic systems. Particular attention is given to synthesis consistency, performance variation across repeated cycles, and resistance to photocorrosion and material degradation under realistic operating conditions. These considerations provide mechanistic insights and help identify future research directions. The discussion highlights the environmental impact of antibiotic contamination, the principles of photocatalytic degradation, and recent advances in nanostructured photocatalytic materials for sustainable wastewater treatment. By emphasizing the unique properties, reproducibility, and durability of 1D nanomaterials, this review presents a distinct and focused perspective on addressing persistent antibiotic pollutants in water.

Identifiers

PMID42040403
PMCPMC13103806

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.